Abstract: The embodiments herein disclose a dental anti-corrosive and anti-fatigue chemical composition. The chemical composition stabilizes the passivating oxide layer and reduces the corrosion specifically fretting corrosion. The chemical composition is capable of increasing the fatigue resistance of NiTi rotary instruments lead to increased number of cyclic fatigue in the dental instruments. The chemical composition is synthesized by mixing sodium chloride NaCl (3.5 wt %) and 3-methoxypropylamine (MOPA) 3000 ppm solution (pH=11.1). The chemical composition is stored in carbon steel, stainless steel or aluminum. The chemical composition is applied to the NiTi rotary instruments are by 5 mL of the anticorrosive chemical composition for 24 hours. After root canal treatment and before next time usage the used instruments are cleaned and sterilized. After sterilization, the instruments are immersed inside the solution for 24 hours. After 24 hours the instruments are ready for the next treatment.

Abstract: The present invention provides a method of treating pathologies resulting from neovascular growth in the eye such as those manifested as retinopathy of prematurity, diabetic retinopathy and macular degeneration. The invention comprises the administration of an effective amount of calcitriol that is administered at doses less than toxicity and results in a significant reduction in the formation of neo-vascular growth. The invention can be used to treat existing diseases or prophylactically to treat those at risk.

Abstract: Methods and compositions for treating pathologies resulting from neovascular growth in the eye such as those manifested as retinopathy of prematurity, diabetic retinopathy and macular degeneration. The invention comprises the administration of an effective amount of vitamin or a salt, prodrug or derivative thereof, administered at doses less than toxicity and results in a significant reduction in angiogenesis or the formation of neo-vascular growth. The invention can be used to treat existing diseases or prophylactically to treat those at risk.

Abstract: The present invention provides a method of treating pathologies resulting from neovascular growth in the eye such as those manifested as retinopathy of prematurity, diabetic retinopathy and macular degeneration. The invention comprises the administration of an effective amount of calcitriol that is administered at doses less than toxicity and results in a significant reduction in the formation of neo-vascular growth. The invention can be used to treat existing diseases or prophylactically to treat those at risk.